Cases

SINERGIA

SINERGIA

LifeTec Group, through its multidisciplinary collaboration with SINERGIA consortium, is focusing on the research of an ex vivo perfused liver platform, called BioLiver, to reduce and refine animal testing, provide more insights compared to conventional in vitro models, and to offer new services for studies of liver interventions and tissue response to drug treatment.
Read more about SINERGIA
SAFE-CAB

SAFE-CAB

LifeTec Group has joined the SAFE-CAB project, aimed at developing a new, minimally invasive coronary artery bypass procedure, and they will co-develop a training procedure and a realistic training environment to prepare surgeons and cardiologists to use the new technology.
Read more about SAFE-CAB
CARMAT SA

CARMAT SA

Carmat is the designer and developer of the world’s most advanced total artificial heart. With this product, they aim to provide a therapeutic alternative for people suffering from end-stage biventricular heart failure.
Read more about CARMAT SA
VPH-CASE

VPH-CASE

The VPH-CaSE project, in which LifeTec Group is involved, focuses on personalized cardiovascular support and improvements to the PhysioHeart™ ex vivo beating heart model are being made to enhance its usability and lifespan, in order to evaluate cardiological and cardiac surgical treatments more reliably.
Read more about VPH-CASE
CarBon

CARBON

The CarBon project aims at developing new treatment options for large bone defects and osteoarthritis. Within the project LifeTec Group is aiming at developing disease models in order to assess new treatment options.
Read more about CARBON
PHILIPS case

PHILIPS RESEARCH

The Philips Research team developed an innovative ultrasound imaging solution, and established a passive-heart setup at their facilities with the help of LifeTec Group to get controllable, in-vivo like data in a controlled and safe environment, without ethical concerns, and for a lower budget.
Read more about PHILIPS RESEARCH
Oxiplenish

OXIPLENISH

LifeTec Group performed a thorough validation and verification study on Oxiplenish's donor organ transport system (Airdrive), covering all necessary parameters and including consultation with regulatory advisory and notified bodies, resulting in optimized performance and continued cooperation with Oxiplenish on the road to CE marking.
Read more about OXIPLENISH
Musicare

MUSICARE

The MUSICARE program developed an innovative catheter-based therapy for cardiovascular pathologies, and LifeTec Group is conducting research on the use of light and materials to improve its effectiveness.
Read more about MUSICARE
BIOGEL

BIOGEL

BIOGEL is a European research program developing hydrogels for medical applications, with LifeTec Group creating physiologically relevant 3D in vitro and ex vivo platforms to study biomaterial behavior and tissue interaction, improving biomaterial test methods for a more predictable translation to pre-clinical practice.
Read more about BIOGEL
BIP-UPY

BIP-UPY

The BIP-UPy project has developed bioactive implants for intracranial aneurysms and pelvic organ prolapse/stress urinary incontinence, and LifeTec Group has developed in vitro/ex vivo model systems to assess their mechanical loading conditions and performance under long-term ex vivo culture.
Read more about BIP-UPY
Hydrozones

HYDROZONES

HydroZONES aims to regenerate articular cartilage using bio-functional hydrogel-based implants and LifeTec Group developed a 3D ex vivo long-term culture and test system for cartilage implants, allowing for better interpretation of outcomes and predictable translation into pre-clinical practice, thus saving time, risks, costs and animal lives.
Read more about HYDROZONES